AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Jglime M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Jeevan Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Jglime M 1mg/500mg Tablet SR

Metformin/Glibenclamide 1mg/500mg extended-release tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by managing blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar control. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney damage, vision loss, neuropathy, and limb complications. This medication forms part of a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle adjustments significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by sweating, dizziness, headache, and tremors. Maintain regular mealtimes and carry a quick-acting glucose source, such as sweets or juice. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Disclose any history of heart disease to your physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Jglime M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Jglime M 1mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Jglime M 1mg/500mg Extended-Release tablet with a meal.

Common Side effects of Jglime M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Jglime M 1mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. The Jglime M 1mg/500mg Extended-Release tablet should be administered with a meal.

How Jglime M 1mg/500mg Tablet SR works:

Jglime M SR tablets (1mg/500mg) combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Jglime M 1mg/500mg SR tablet ingestion is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Jglime M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Extended-release Jglime M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Jglime M 1mg/500mg Tablet SR, potentially requiring dosage modification. Physician consultation is essential. Jglime M 1mg/500mg Tablet SR is contraindicated in those with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Jglime M 1mg/500mg Tablet SR cautiously, as dosage modification may be necessary. Patients with severe liver disease should avoid this medication. For those with mild to moderate liver disease, a low starting dose is typically advised. Physician consultation is recommended.

What if you forget to take Jglime M 1mg/500mg Tablet SR :

Should you forget a Jglime M 1mg/500mg Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Jglime M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Jglime M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Jglime M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Jglime M 1mg/500mg Tablet SR and seek immediate medical attention.
Jglime M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Jglime M 1mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Jglime M 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplementation with vitamin B12 is recommended by some researchers.
Jglime M 1mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Jglime M 1mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Jglime M 1mg/500mg Tablet...
44
MRP 54
18% off